Lagging Pfizer Revenue Reinvigorates M&A Speculation

Lagging Pfizer Revenue Reinvigorates M&A Speculation

Pfizer Inc. reported a revenue drop on Tuesday thanks in part to once-hot products that continue to lag, ramping up pressure for the company to renew its acquisition push for AstraZeneca PLC or swallow another well-established drugmaker with a robust ...read more

  • Tags: